SRSF10 facilitates HCC growth and metastasis by suppressing CD8+T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapy.
Luo X, Zhang Z, Li S, Wang Y, Sun M, Hu D, Jiang J, Wang Y, Ji X, Chen X, Zhang B, Liang H, Li Y, Liu B, Xu X, Wang S, Xu S, Nie Y, Wu K, Fan D, Liu D, Huang W, Xia L.
Luo X, et al. Among authors: xia l.
Int Immunopharmacol. 2024 Jan 25;127:111376. doi: 10.1016/j.intimp.2023.111376. Epub 2023 Dec 18.
Int Immunopharmacol. 2024.
PMID: 38113691
Free article.